Assets in USD of Can-Fite BioPharma Ltd. from Q4 2018 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary
Can-Fite BioPharma Ltd. quarterly Assets history and growth rate from Q4 2018 to Q2 2025.
  • Can-Fite BioPharma Ltd. Assets for the quarter ending June 30, 2025 was $7.72M, a 30.4% increase year-over-year.
Assets, Quarterly (USD)
Assets, YoY Quarterly Growth (%)

Can-Fite BioPharma Ltd. Quarterly Assets (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 $7.72M +$1.8M +30.4% Jun 30, 2025 6-K 2025-08-28
Q4 2024 $9.12M -$869K -8.7% Dec 31, 2024 6-K 2025-08-28
Q2 2024 $5.92M -$5.11M -46.3% Jun 30, 2024 6-K 2024-08-29
Q4 2023 $9.99M +$706K +7.61% Dec 31, 2023 20-F 2025-04-14
Q2 2023 $11M -$3.71M -25.2% Jun 30, 2023 6-K 2023-08-31
Q4 2022 $9.28M -$11M -54.2% Dec 31, 2022 20-F 2024-03-28
Q2 2022 $14.7M +$5.07M +52.3% Jun 30, 2022 6-K 2022-08-25
Q4 2021 $20.3M +$10.7M +113% Dec 31, 2021 20-F 2023-03-30
Q2 2021 $9.68M -$3.12M -24.4% Jun 30, 2021 6-K 2021-08-26
Q4 2020 $9.52M +$1.35M +16.5% Dec 31, 2020 20-F 2022-03-24
Q2 2020 $12.8M -$867K -6.34% Jun 30, 2020 6-K 2020-08-27
Q4 2019 $8.17M +$222K +2.79% Dec 31, 2019 20-F 2021-03-25
Q4 2018 $7.95M +$338K +4.44% Dec 31, 2018 6-K 2020-06-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.